Microbiome Therapeutics

CAMBRIDGE, Mass., July 8, 2026 Seres Therapeutics announced encouraging topline results from an investigator-sponsored clinical trial (IST) evaluating SER-155...

CAMBRIDGE, Mass., April 9, 2026 Vedanta Biosciences, a late clinical-stage biopharmaceutical company, has announced new scientific presentations showcasing its...

GREENFIELD, INDIANA, UNITED STATES — February 18, 2026 BiomEdit has initiated the pivotal field safety trial for its lead...

GHENT, Belgium | January 9, 2026 — MRM Health announced that the U.S. Food and Drug Administration (FDA) has...